In Joo Kim

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Cystatin C as an Early Biomarker of Nephropathy in Patients with Type 2 Diabetes

Yun Kyung Jeon, Mi Ra Kim, Jung Eun Huh et al. · Journal of Korean Medical Science · 2011 · 144 citations · Full text

Glomerulonephritis, Urology, Renal Disease +15

Urinary Cystatin C and Tubular Proteinuria Predict Progression of Diabetic Nephropathy

Sang Soo Kim, Sang Heon Song, In Joo Kim et al. · Diabetes Care · 2012 · 136 citations · Full text

2016 Revised Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Thyroid Cancer

Ka Hee Yi, Eun Kyung Lee, Ho‐Cheol Kang et al. · International Journal of Thyroidology · 2016 · 103 citations · Full text

Thyroid Nodules, Thyroid Disease, Thyroid Disorders +4